Specialty Pharmacy

Telemedicine and connected devices are emerging as technologies to provide greater access and convenience to care for those who can defer treatment by way of an in-person consultation.

At the 2020 American Society of Clinical Oncology Virtual Scientific Program, researchers presented a recent study that is the largest to date analyzing CLL treatment patterns among VHA patients between 2013 and 2018.

Trastuzumab deruxtecan (T-DXd) (Enhertu) demonstrated strong efficacy in a phase 2 trial for treatment of HER2-positive metastatic breast cancer.

Treatment with avelumab (Bavencio) potentially cured 8 of 15 women in a trial with gestational trophoblastic tumors resistant to single-agent chemotherapy.

Ensuring patients continue receiving life-sustaining home infusions that were traditionally administered in the hospital or hospital clinic settings is of the upmost importance.

Atezolizumab (Tecentriq) approved in combination with bevacizumab (Avastin) for the treatment of patients with unresectable or metastatic hepatocellular carcinoma who have not received prior systemic therapy.

In 2017 alone, there was an estimated 785 fewer cancer deaths in states that adopted Medicaid expansion.

At 5 years follow up, the data showed that the OS for women on olaparib was 42.1%, while the placebo OS was 33.2%.

Artificial intelligence will inevitably play a major role in hub services, improving efficiency and speed to therapy.

Pharma companies that shift their attention to what providers, payers, and patients are asking for will profit from the growing worldwide market on preventative care.

In an era of high-priced drugs, health care stakeholders continue to explore alternative pricing models that focus on the concept of value-based drug purchasing models.

The therapy is approved for patients with squamous or non-squamous disease and regardless of programmed death-ligand 1 (PD-L1) expression.

The National Home Infusion Foundation (NHIF) announced yesterday that the winner of the 2020 Outstanding Abstract Achievement Award is Rachel Dellevar, PharmD.

According to the study authors, patients with MS who underwent the 4-week mindfulness training not only showed greater improvement in processing speed and regulating negative emotions than those who did not participate in any training, but they also improved compared with those who tried adaptive cognitive training (ACT).

The cause of the majority of rare diseases is associated with 80% of the cases being genetically linked due to inheritance of mutated genes.

The new formulation of twice-a-day deferiprone 1000 mg oral tablets eliminates the mid-day dose, and provides patients with the ability to reduce serum ferritin levels, and cardiac and liver iron.

Over time, hub operations have matured to act as sort of a middleman between manufacturers and specialty pharmacies.

Nearly 30% of the 2773 patients with COVID-19 received systemic coagulation during their time in the hospital.

According to study findings published in Cancer, mammography screenings reduce the rates of advanced and fatal cancers by more than 40%.

Many pharmaceutical manufacturers consider accreditation a prerequisite when either building their network or adding pharmacies to their network.

As the pharmacy industry continues to change, certified pharmacy technicians have the opportunity to step into new roles, taking on more responsibility in helping their pharmacy teams as well as the patients they serve.

Autumn Zuckerman, director of specialty pharmacy at Vanderbilt University Medical Center, and JoAnn Stubbings, a professor at the University of Illinois at Chicago College of Pharmacy, discuss the role of specialty pharmacists in guiding patients throughout their journey.

The intention of risk evaluation and mitigation strategy programs is to ensure that the patient gets potentially dangerous drugs that are monitored appropriately.

The approval is based on an interim analysis from the phase 3 IMpower110 study, which showed atezolizumab monotherapy improved overall survival by 7.1 months compared with chemotherapy in people with high PD-L1 expression, according to a press release.

The placement of clinical pharmacists at the nexus of functional pharmacogenomics and in specialty pharmacy care makes good sense.

The anti-cancer medicine venetoclax may improve the current therapy for estrogen receptor-positive (ER+) breast cancer.

Ripretinib is indicated for adult patients who have received prior treatment with 3 or more kinase inhibitor therapies, including imatinib, according to an FDA press release.

The NASP Challenge is an unique opportunity to identify innovative ideas and creative solutions focused on enhancing the specialty pharmacy patient jouney.